{"page_content": "2020 CORPORATE SOCIAL RESPONSIBILITY REPORT12\nABOUT SERVE TRANSFORM ADVANCE REDEFINE ETHICS & COMPLIANCE REPORTING INDEX   Dear CommunitiesFOCUS   \nAREAASPIRATION METRIC2019   \nSTATUS2020   \nSTATUSMORE   \nINFORMATION\nSupport people \naffected by rare \ndiseases and \ndevastating \nconditions and \ntheir caregivers \nthroughout the \npatient journeyGenerate real-world evidence to \ndocument the benefits and safety of \nAlexion treatmentsOngoing Ongoing Page 34\nInclude patient and caregiver perspective, \nadvice and input, as appropriate, into \nearly clinical development plans and \nidentified Phase II/III Alexion clinical trials \nto inform protocols and where possible, \npatients\u2019 informed consent documentsOngoing Ongoing Pages 27, 29\nBe a key influencer of patient organization \nengagement standards across the \nindustry through ongoing, proactive \nthought leadershipOngoing Ongoing Page 31\nBecome the most \nrewarding company \nto work forImplement key culture initiatives to drive \npatient centricity year over yearOngoing Ongoing Pages 43, 46\nAdvance employee experience priorities \nto drive patient centricity year over yearOngoing Ongoing Pages 45-46\nCreate more patient-centric  \ndecision-makingOngoing Ongoing Page 46CSR-STAR ASPIRATIONS AND METRICS (CONTINUED)\nTRANSFORM\nPATIENT LIVES\nADVANCE\nOUR PEOPLE AND \nOUR COMPANY", "metadata": {"source": "NASDAQ_ALXN_2020.pdf", "page": 11, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}